Cantor Fitzgerald Downgrades Fennec Pharmaceuticals Inc. (FENC) to Neutral
Tweet Send to a Friend
Cantor Fitzgerald analyst Charles Duncan downgraded Fennec Pharmaceuticals Inc. (NASDAQ: FENC) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
